<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01283568</url>
  </required_header>
  <id_info>
    <org_study_id>GAMALINEHIPERICIN</org_study_id>
    <nct_id>NCT01283568</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of Gamaline+Hipericin in PMS</brief_title>
  <acronym>GH</acronym>
  <official_title>Phase IV Study of Combined GAMALINE and HIPERICIN for Treating Pre-Menstrual Syndrome and Vasomotor Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phytopharm Consulting Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Herbarium Laboratorio Botanico Ltda</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Federal University of Health Science of Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Phytopharm Consulting Brazil</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      GAMALINE is already register for PMS and HIPERICIN as antidepressive drug. Both plant
      extracts. The investigators will try the mixture and see if the vasomotor symptoms will
      disappear. The investigators expect that together all symptoms will be covered better than
      Gamaline alone. The investigators will run for 180 days measuring at T0, T1 and T6 (starting
      point, 30 days and 180 days).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This protocol wants to show the advantages for the mixture GAMALINE 900mg+HIPERICIN 300mg - 2
      herbal extracts for PMS treatment against the individual use of GAMALINE
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">February 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Edema</condition>
  <condition>Depression</condition>
  <condition>Hot Flashes</condition>
  <condition>Anxiety</condition>
  <condition>Irritability</condition>
  <arm_group>
    <arm_group_label>1 - Gamaline+Hipericin - fertile women</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>2- Gamaline+Hipericin - climateric women</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>3- Gamaline- control - fertile women</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>4 - Gamaline control - climateric women</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Only women from 25 to 55 years old with PMS symptoms
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  climacteric pre-menopausal women between 45 e 55 anos

          -  women between 25 e 44 anos

        Exclusion Criteria:

          -  Age inferior 25 anos or superior 55 anos and/or decline invitation.

          -  Patients pos-menopause

          -  Under hormone therapy

          -  Thyroid disease

          -  Under psychiatric therapy or medication

          -  History for allergies and hypersensitivity to one or both extracts

          -  Breast feeding or pregnancy

          -  No knowledge for writing and/or reading
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karla F Deud José, Pharm PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Phytopharm Consulting Brazil - karla@phytopharm.com.br</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carla Vanin, MD MSc PhD</last_name>
    <phone>+55 51 99628061</phone>
    <email>carlavanin@terra.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ambulatório de Ginecologia e Obstetrícia ISCMPA</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90020-090</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Vanin, MD MSc PhD</last_name>
      <phone>+55 51 32148080</phone>
      <email>carlavanin@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Raquel P Dibi, MD MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carla Vanin, MD MSc PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2011</study_first_submitted>
  <study_first_submitted_qc>January 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2011</study_first_posted>
  <last_update_submitted>November 25, 2011</last_update_submitted>
  <last_update_submitted_qc>November 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PMS, climacteric, depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Hot Flashes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

